Health AI Central
Share:
Peer-Reviewed Publication
Photoacoustics2018;1230-45.December 1, 2018Journal Article

Clinical optoacoustic imaging combined with ultrasound for coregistered functional and anatomical mapping of breast tumors.

A A Oraevsky1, B Clingman2, J Zalev3, A T Stavros2, W T Yang4, J R Parikh4
1TomoWave Laboratories, Houston, TX, United States.
2Seno Medical Instruments, San Antonio, TX, United States.
3Department of Physics, Ryerson University, Toronto, Canada.
4Department of Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
PubMed PMC DOI PDF

Abstract

Optoacoustic imaging, based on the differences in optical contrast of blood hemoglobin and oxyhemoglobin, is uniquely suited for the detection of breast vasculature and tumor microvasculature with the inherent capability to differentiate hypoxic from the normally oxygenated tissue. We describe technological details of the clinical ultrasound (US) system with optoacoustic (OA) imaging capabilities…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.